Species Identity &
Genomic Confirmation
Species confirmed as Ganoderma sichuanense Zhao & Zhang (= G. lingzhi) by independent genomic sequencing
Inqaba Biotechnical Industries (Pty) Ltd conducted dual-marker ITS and EF1-alpha sequencing of the MG-LZ8™ source culture. ITS region: 99.69% identity match. EF1-alpha region: 100% identity match. GenBank accession numbers OR685549.1 (ITS) and JX029974.1 (EF1-alpha) provide independently verifiable links to deposited reference sequences at NCBI.
| Marker | Identity Match | GenBank Accession | Species Confirmed |
|---|---|---|---|
| ITS Region | 99.69% | OR685549.1 | G. sichuanense (= G. lingzhi) |
| EF1-alpha Region | 100% | JX029974.1 | G. sichuanense (= G. lingzhi) |
The same analysis confirmed a commercially available product from a high-profile international mycology supplier as Ganoderma sessile — a taxonomically distinct North American species — misidentified as G. lucidum in that product's labelling.
Pre-Clinical
Immunological Validation
Measurable innate and adaptive immune response in mice, with no effect on cancer cell growth
Prof. Vaclav Větvička, Department of Pathology, University of Louisville, Kentucky USA — one of the world's leading researchers in beta-glucan immunology — conducted an independent, commissioned pre-clinical study of MG-LZ8™ in 2018.
Prof. Větvička scaled the mouse doses (50 and 100 μg per mouse) from the 15 mg human dose, and the immune response rose with dose across both. At the 100 μg dose, at 24 hours, IL-2 production increased from 1.1 pg/ml to 262.4 pg/ml (238-fold), and phagocytosing neutrophils (the first-responder immune cells) increased from 31.1% baseline to 47.2% (+51.7%). In cell culture at 48 hours, the extract showed no significant effect on the growth of four cancer cell lines (MCF-7, HL-60, NCI-H23, PC-3) at any dose tested.
Compound Profile &
Comparative Analysis
Two benchmarks, side by side: MG-LZ8™, the antler benchmark (~13:1), and the internationally recognised 16:1 conk dual-extract benchmark. Each carries the triterpenoid signature of its own morphology.
In October 2021, MG-LZ8™ was analysed side by side with the internationally recognised 16:1 conk dual-extract benchmark under identical LC-MS/QTOF conditions. The mass spectrometry was performed by Prof. Marietjie Stander at the Central Analytical Facility (CAF), Stellenbosch University; the written report was compiled by Dr. T. Little of Raluka Biotech.
Both extracts are rich in triterpenoids, and the distribution between them differs. MG-LZ8™ carries higher proportions of ganoderic acid B, ganoderic acid C2, DHTLO and the compound at RT 28.5; the conk extract carries more ganoderic acids A, D and F and ganoderenic acid B. Two compounds set the antler extract apart: GA/B (RT 32.17) at 8.07% against 0.14% in the conk extract, and a compound at RT 25.84 detected in MG-LZ8™ only.
Percentages below are relative proportions of the most abundant compounds in each sample, not concentrations. Compound identities are provisional pending full MS/MS fragmentation. A three-way run comparing FS-19, MG-LZ8™ and a fresh conk benchmark sample is under way with Prof. Stander; the results will be added here.
| Compound | Conk Benchmark 16:1 (%) | MG-LZ8™ (%) | MG-LZ8™ vs conk |
|---|---|---|---|
| Ganoderic Acid A (GA) | 17.73 | 16.13 | −9% |
| Ganoderic Acid B (GB) | 7.00 | 8.40 | +20% |
| Ganoderic Acid D (GD) | 11.00 | 8.68 | −21% |
| 12-Acetoxyganoderic Acid F | 8.81 | 6.97 | −21% |
| Ganoderenic Acid B (GEB) | 9.75 | 5.29 | −46% |
| DHTLO | 5.66 | 7.05 | +25% |
| Ganoderic Acid C2 (GC2) | 4.97 | 6.03 | +21% |
| GA/B (RT 32.17) | 0.14 | 8.07 | Antler marker (conk near detection limit) |
| Unknown (RT 28.5) | 3.91 | 5.51 | +41% |
| Unknown (RT 25.84) | Not detected | 3.07 | MG-LZ8™ only |
MG-LZ8™ full triterpenoid spectrum vs two detectable peaks in registered SA pharmaceutical Reishi product
A separate LC-MS/QTOF analysis compared MG-LZ8™ against a commercially available Reishi product from a registered South African pharmaceutical supplier. MG-LZ8™ produced a rich, well-resolved chromatographic profile with 11 specific triterpenoid compounds identified. The comparator product produced two detectable peaks.
β-Glucan
Quantification
β-glucan confirmed at 9.10% w/w (low heat extract) in MG-LZ8™ finished extract by Megazyme K-YBGL assay
The Neogen/Megazyme K-YBGL assay was applied to MG-LZ8™ finished extract (sample H23-25401). At 9.10% beta-glucan in a 15mg capsule, MG-LZ8™ delivers 1.37mg beta-glucan per dose. The same run confirmed the 16:1 conk extract at 20.31% beta-glucan (which confirms a high-heat process). The 9.10% figure represents the finished extract from a controlled, low-temperature, dual-phase extraction. A second Megazyme run will be conducted to complete the full glucan profile; the current result reflects a dual stage extraction. A third high-heat extraction will be added to the process, and Prof Marietjie Stander will test the new improved extract... named; "FS-19"
Purity, Safety
& Heavy Metals
Starch below detection limit. Glucose the only sugar present.
SANAS-accredited laboratory Mérieux NutriSciences (accreditation T0350) conducted a full purity and safety analysis of MG-LZ8™ in October 2023.
| Parameter | Result | Limit / Significance |
|---|---|---|
| Starch | <0.50g/100g (below detection) | Confirms zero grain substrate contamination |
| Total fat | 25.6g/100g | Consistent with a retained lipid-soluble fraction |
| Glycaemic carbohydrates | 2.71g/100g (glucose only) | Confirms absence of starch-derived carbohydrate load |
Heavy metals confirmed well below international limits at raw material stage
| Heavy Metal | Result | International Limit | Margin |
|---|---|---|---|
| Lead | 0.171 ppm | <3.0 ppm | 17.5× below limit |
| Cadmium | 0.018 ppm | <1.0 ppm | 55× below limit |
| Mercury | 0.002 ppm | <0.10 ppm | 50× below limit |
Extraction Methodology
& Consistency
29× extraction multiplier confirmed by independent HPLC. 12× antler-morphology triterpenoid density confirmed by expert chromatographic interpretation.
Verve Dynamics Laboratory (R.P. Davies, Somerset West) conducted independent HPLC comparative analysis in July 2017. The ethanolic only extract showed a 29-fold increase in total triterpenoid content compared to raw antler material. Expert chromatographic interpretation of the antler vs standard conk comparison found approximately 12-fold higher triterpenoid concentration in the antler form.
A breakthrough in Ganoderma extraction
MG-LZ8™ is the product of two innovations working together: antler-morphology cultivation, which harvests the mushroom at its triterpenoid-rich developmental stage, and Mushroom Guru’s proprietary controlled, low-temperature, dual-phase extraction, refined over 13 years.
The finished extract is concentrated at approximately 13:1 (batch range 12.8–13.9:1). That is a tighter ratio than the 16:1 conk benchmark, because the starting material is already richer: an extraction ratio measures how much raw material goes in, not how much active compound comes out.
Combined cascade: 12 × 29 = 348×
One 15mg capsule of MG-LZ8™ delivers the active compound equivalent of approximately 5,220mg of standard imported Reishi powder.
The 12× and 29× are independent, compounding factors: 12× is a powder-to-powder morphological comparison (antler vs conk); 29× is the extraction multiplier applied to that richer starting material.
Extraction Philosophy: Biological Activity Beyond Glucan Content
MG-LZ8™ is developed around a research-led extraction philosophy that prioritises the characterisation and biological activity of the finished extract, rather than maximising a single compositional marker.
The process uses a controlled, low-temperature extraction stage. One objective is to limit unnecessary heat exposure of potentially heat-sensitive constituents, including proteins. Whether intact LZ-8 protein is retained, and whether it remains biologically active in the finished extract, requires product-specific analytical and functional verification.
Glucan content remains an important compositional measurement, but it is not, by itself, a complete measure of an extract’s biological activity. Mushroom Guru is investigating how extraction conditions influence glucan recovery, protein preservation, chemical composition and biological responses.
This approach distinguishes measurable composition from demonstrated biological activity and recognises that the significance of an extract ultimately requires appropriate experimental validation.
In-house extraction profile met and improved on the original Verve Dynamics validated baseline
Following technology transfer and in-house extraction implementation, Ecogreen Analytics (Gregory Ondrejkovic) independently verified that the current MG-LZ8™ in-house extraction profile met and improved on the original Verve Dynamics validated triterpenoid profile. This confirms that the 348× concentration cascade is maintained across production batches under in-house conditions.
Academic Replication of the
MG-LZ8™ Antler Cultivation Approach
The antler cultivation approach underlying MG-LZ8™ has been recreated under the guidance of Mushroom Guru at the University of the Free State (UFS) as part of master’s research. The work addressed antler formation, cultivation conditions and the developmental stage at harvest.
Miss C. Van der Berg, under the supervision of Prof. B.C. Viljoen (Department of Microbial, Biochemical and Food Biotechnology, University of the Free State), used a Mushroom Guru tissue culture (UFS-GL1) as the founding culture. The Mushroom Guru elevated CO₂ antler induction protocol was reproduced under controlled academic conditions, and antler formation was confirmed within 28 days. Craig Fourie’s prior research on lignocellulosic substrate conversion via Ganoderma mycelium (Fourie, 2015) is cited as primary academic literature within the thesis.
The UFS research concerned cultivation and antler development; it did not reproduce Mushroom Guru’s proprietary extraction process. The extraction technology used to produce MG-LZ8™ remains distinct from the cultivation methodology investigated in the academic research.
The published master’s research provides an academic reference for the cultivation and developmental aspects of the process. Its findings should be interpreted within the scope of the experiments reported in the publication.
Laboratory
Verification Summary
| Laboratory | Key Finding | Date |
|---|---|---|
| Verve Dynamics (R.P. Davies) Somerset West, South Africa | 12× antler-morphology triterpenoid density confirmed. 29× extraction cascade confirmed by HPLC. Dual-phase CoAs issued with full heavy metals and microbiological panels. | July 2017 |
| University of Louisville Prof. Vaclav Větvička, Department of Pathology, Kentucky, USA | Independent commissioned pre-clinical study in mice (50 and 100 μg per mouse). At 24 hours: IL-2 up 238-fold and phagocytosing neutrophils up 51.7% at the 100 μg dose. No significant effect on the growth of four cancer cell lines at 48 hours. | Sep 2018 |
| Stellenbosch University CAF Prof. Marietjie Stander (performed the mass spectrometry); Dr. T. Little, Raluka Biotech (report compiler) | 11 specific triterpenoid compounds identified. Side by side with the internationally recognised 16:1 conk dual-extract benchmark: a distinct antler signature, with GA/B at 8.07% against 0.14% and a compound found in MG-LZ8™ only. Comparator pharmaceutical product: two detectable peaks. | May & Oct 2021 |
| Mérieux NutriSciences SANAS-accredited T0350 | Starch below detection limit. Glucose the only sugar detected. Full nutritional profile, including fat, protein, fibre and fatty acids. | Oct 2023 |
| Neogen / Megazyme K-YBGL | β-glucan confirmed at 9.10% w/w (low-temperature, dual-phase extract) using industry-standard K-YBGL method. Same run confirmed conk benchmark at 20.31% and returned 97% total glucan (67.7% beta, 29.7% alpha) for a South African comparator “extract” — a profile no mushroom extract can produce, indicating added non-mushroom glucan. | Oct 2023 |
| Inqaba Biotechnical Industries Pretoria, South Africa | Species identity confirmed as G. sichuanense Zhao & Zhang (= G. lingzhi). ITS: 99.69%. EF1-alpha: 100%. GenBank accessions OR685549.1 and JX029974.1 provide independently verifiable reference links at NCBI. Dual-marker confirmation places the MG-LZ8™ source culture within the most phylogenetically ancient lineage of G. lingzhi — a finding with direct relevance to compound profile and clinical positioning. | Aug 2025 |
| Ecogreen Analytics Gregory Ondrejkovic | In-house extraction met and improved on the original Verve Dynamics validated profile. Extraction consistency maintained across multiple production batches, confirming successful technology transfer to the Mushroom Guru GMP-audited facility in Strand. | Feb 2025 |
The Antler
Developmental Biology
The antler is not a stress response — it is the mushroom’s natural exploration state, activated by a single environmental signal
Ganoderma sichuanense carries two fully encoded developmental programs in its genome. Which one runs is determined by a single environmental signal: the ratio of CO₂ to oxygen in the immediate atmosphere.
When CO₂ is elevated — as it is underground, inside decaying wood, or in a sealed cultivation environment — the organism activates its exploration program. In the most recent transcriptomic study of elevated CO₂, 5,913 genes changed expression across the study, with almost 3,000 changing in a single fruiting-body comparison (Fang et al., 2026). It grows vertically, elongating and sending structures upward to find oxygen. The reproductive program is held in reserve.
The moment oxygen is detected as the growing tip reaches open air, the signal reverses. The antler program is downregulated. The pileus begins to form, spore production begins, and the organism transitions from exploration to reproduction. The genome study of G. lucidum found triterpenoid content extremely low in mycelium, at its highest in the primordium and falling as the mature fruiting body forms, with 78 triterpenoid-pathway genes switching on before fruiting and off after it (Chen et al., 2012).
Elevated CO₂ signal active. Organism growing vertically toward oxygen. Full secondary metabolite biosynthesis running. Triterpenoid content at its developmental peak (Chen et al., 2012). Reproductive switch held in reserve.
Oxygen signal received. Antler program downregulated. Pileus formation begins. Biological resources redirected from secondary metabolite production to spore production and reproduction. Triterpenoid density falls.
Mushroom Guru harvests exclusively at the antler stage — before the oxygen signal reverses the developmental program.
Glyconutrient Profile —
The Communication Layer
MG-LZ8™ contains five of the eight essential saccharides required for immune cell communication — confirmed by independent MS/QTOF and nutritional analysis
Research by Dr. Steve Nugent identified eight monosaccharides required for the glycoprotein structures on cell surfaces that govern immune cell-to-cell communication. Modern diets typically provide only two of these eight.
Mannose and fucose are of particular immunological significance. Mannose engages the mannose receptor CD206 on macrophages and dendritic cells. Fucose is a key component of the selectin-ligand structures that govern immune cell migration and tissue homing.
The LZ-8 immunomodulatory protein — the first mushroom immune protein ever characterised, isolated from Ganoderma — has a structure with functional homology to the Fc domain of human immunoglobulins.
Clinical Translation —
What the Data Means in Practice
Laboratory numbers translated into clinical and formulation relevance
| Laboratory Finding | Clinical / Formulation Relevance |
|---|---|
| IL-2 238-fold increase at 24 hours (Větvička, 2018) | IL-2 is the primary cytokine governing T-cell proliferation and immune surveillance. A 238-fold rise signals strong adaptive immune activation, through the beta-glucan / Dectin-1 pathway that mice and humans share. This is pre-clinical evidence; human trials are the next step. |
| Phagocytosing neutrophils +51.7% at 24 hours | Neutrophils are the body’s first-responder cells. A +51.7% rise in phagocytosis within 24 hours indicates a markedly more active innate response. |
| No significant effect on four cancer cell lines at any dose | The extract neither stimulated nor inhibited cancer cell growth in culture. This is a cell-culture finding only; healthy-cell and human safety were not tested in this study. |
| Starch below detection limit. | For formulators: clean label calculations, no hidden carbohydrate load. For practitioners: suitable for low-carbohydrate or grain-free protocols. |
| 15mg dose — 348× concentration cascade | For formulators: 585mg+ of capsule space remains after a full 15mg MG-LZ8™ serving in a standard size 00 capsule, leaving room for co-ingredients. |
| GA/B compound (RT 32.17) — detected in MG-LZ8™, near detection limit in the comparator | Identity is provisional pending full MS/MS fragmentation. For pharmaceutical partners: a research opportunity worth characterising. |
| Five saccharides confirmed — including mannose and fucose | Mannose engages CD206 on macrophages and dendritic cells. Fucose supports selectin-ligand structures governing immune cell migration. Both absent from most supplement formats. |
Note for Oncology Practitioners
MG-LZ8™ is being developed as a 90-day protocol for post-treatment immune recalibration. The specific research hypothesis — that MG-LZ8™’s neutrophil activation capacity supports MPO-mediated clearance of carbon-based nanocarriers used in oncological drug delivery — is the subject of a proposed clinical trial at Stellenbosch University and Tygerberg Academic Hospital. Practitioners working in this space are invited to make contact directly.
Analytical documentation, sample quantities, and practitioner pricing available on request.
MG-LZ8™ is selective about the formulations and protocols it enters.
Request documentation or samples
Original laboratory reports, sample quantities, practitioner pricing, and formulator briefs available to authorised practitioners, formulators, and regulatory parties on request.
Request documentation or samples →